Can vortioxetine (Brintellix) cause hypertension, particularly in patients with a history of hypertension or cardiovascular disease?

Does Vortioxetine Cause Hypertension?

Vortioxetine does not cause clinically significant hypertension and has minimal effects on blood pressure in clinical practice. 1

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for vortioxetine (TRINTELLIX) explicitly states that the drug "has not been associated with any clinically significant effects on vital signs, including systolic and diastolic blood pressure and heart rate, as measured in placebo-controlled studies." 1 This represents the highest quality evidence available, as it reflects comprehensive safety data from the drug's registration trials.

Clinical Trial Data on Blood Pressure Effects

• In 6-8 week placebo-controlled studies, vortioxetine showed no clinically important changes in blood pressure measurements 1
• In a 6-month double-blind, placebo-controlled maintenance study, there were no significant blood pressure differences between vortioxetine and placebo-treated patients 1
• The pharmacokinetic profile of vortioxetine, with its multimodal mechanism targeting serotonin receptors and transporters, does not include mechanisms that would be expected to elevate blood pressure 2

Comparison with Other Antidepressants

Vortioxetine is among the safest antidepressants regarding blood pressure effects, particularly when compared to other classes:

• SNRIs (particularly venlafaxine) carry a significantly greater risk of hypertension, with sustained hypertension rates of 4.8% 3, 4
• SSRIs like fluoxetine show sustained hypertension rates of only 1.7%, similar to placebo (2.1%) 4
• Vortioxetine demonstrates even more neutral blood pressure effects than traditional SSRIs, with no documented sustained hypertension in clinical trials 1, 3

The review by Carvalho et al. specifically notes that serotonin-reuptake modulators like vortioxetine have "limited effects on blood pressure," distinguishing them from drugs like venlafaxine that have "greater effects on the sympathetic nervous system" 3

Special Populations and Cardiovascular Disease

Patients with pre-existing hypertension or cardiovascular disease can safely use vortioxetine without blood pressure concerns:

• The drug showed no significant blood pressure changes in patients with preexisting, stable cardiovascular disease (including hypertension) 4
• No dose adjustments are required based on cardiovascular status 2
• Vortioxetine's neutral cardiovascular profile makes it particularly suitable for elderly patients and those with cardiovascular comorbidities 3

Monitoring Recommendations

While vortioxetine does not cause hypertension, routine clinical practice should include:

• Baseline blood pressure measurement before initiating any antidepressant therapy 5, 6
• No specific blood pressure monitoring is required for vortioxetine beyond standard clinical care 1
• This contrasts with SNRIs like venlafaxine, where regular blood pressure monitoring is recommended due to documented hypertensive effects 7, 3

Common Pitfalls to Avoid

• Do not confuse vortioxetine with venlafaxine: Venlafaxine (an SNRI) causes dose-related blood pressure increases of 2-4 mmHg and can prevent weight loss-induced decreases in blood pressure 7. Vortioxetine has no such effects 1
• Do not withhold vortioxetine from patients with hypertension: The drug's neutral blood pressure profile makes it safe for use in hypertensive patients 1, 3
• Do not assume all antidepressants affect blood pressure similarly: The class of antidepressant matters significantly, with SSRIs and serotonin modulators like vortioxetine having minimal effects compared to SNRIs and tricyclics 3

Clinical Bottom Line

Vortioxetine can be prescribed to patients with or without hypertension without concern for blood pressure elevation. The FDA labeling, clinical trial data, and comparative reviews consistently demonstrate that vortioxetine has no clinically significant effects on blood pressure, making it one of the safest antidepressants from a cardiovascular standpoint 1, 3. No special blood pressure monitoring beyond routine clinical care is necessary when prescribing this medication 1.